What it is
Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, evidence-based talk therapy for chronic insomnia. It targets the thoughts and behaviors that keep insomnia going rather than using medication. CBT-I combines sleep restriction (temporarily limiting time in bed to match actual sleep time), stimulus control (using the bed only for sleep and sex), sleep hygiene education, cognitive therapy (challenging unhelpful beliefs like “I’ll never sleep again”), and often relaxation training. Programs typically run 4 to 8 sessions; the MsFLASH trial used 6 telephone sessions over 8 weeks. CBT-I can be delivered face-to-face, by telephone, or online.
How well it works
Evidence for CBT-I in menopausal women comes from the MsFLASH CBT-I Trial (McCurry et al., JAMA Internal Medicine, 2016), a randomized clinical trial of 106 perimenopausal and postmenopausal women with insomnia and hot flashes. After 8 weeks of telephone-based CBT-I, Insomnia Severity Index scores dropped by 9.9 points, compared to 4.7 points in the menopause education control group, a statistically significant difference (P<.001). At 8 weeks, 70% of CBT-I participants had ISI scores in the no-insomnia range, compared to 24% of controls. Improvements were sustained at 24 weeks, with 84% of CBT-I participants in the no-insomnia range versus 43% of controls. A 2025 meta-analysis of 11 RCTs (n=973) confirmed that CBT-I significantly improves sleep quality and reduces insomnia severity in menopausal women, whether it is delivered face-to-face or remotely.
The NAMS 2023 position statement recommends cognitive behavioral therapy as a Level I intervention for vasomotor symptoms (good and consistent scientific evidence). It cites a pooled analysis of MsFLASH trials in which women with hot flashes and insomnia improved with CBT for insomnia, but its recommendations cover hot flashes, not insomnia itself. The UK’s NICE guideline suggests considering menopause-specific CBT for sleep problems that come with hot flashes. The American College of Physicians recommends CBT-I as first-line treatment for chronic insomnia in all adults, ahead of sleep medications.
Side effects and cautions
CBT-I does not involve medication, so it has no drug side effects. According to the American Academy of Sleep Medicine guideline, the main downsides are daytime sleepiness and fatigue, irritability, and trouble concentrating early in treatment, when sleep restriction shortens time in bed. These effects usually improve over time and typically resolve by the end of treatment. The guideline notes that sleep restriction may be contraindicated for people prone to mania or hypomania, people with poorly controlled seizure disorders, and people in high-risk jobs such as drivers or heavy machinery operators.
Where to get it
In the MsFLASH trial, a menopause counselor delivered CBT-I, with the first session in person and the rest by telephone. A 2025 review supports nurse-led CBT-I delivered face-to-face or remotely, and NICE lists face-to-face, remote, group, and self-help options. Marketplace health plans must cover psychotherapy as an essential health benefit. Check our provider directory for clinics near you.
